Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
Dr. Martens plc (the "Company") announces that it has been notified of the following transaction in the Company's Ordinary 1p shares undertaken on behalf of a director / person discharging managerial responsibility ("PDMR").
Shortly after joining the Company on 13 May, Giles Wilson, Chief Financial Officer, received a cash payment to compensate him for the loss of bonuses he stood to receive at his previous employer. In line with the Company's Remuneration Policy, one third of the net amount payable was subsequently used to purchase shares which Giles is required to hold for a minimum of two years.
The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a) | Name | Giles Wilson | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | PDMR (Chief Financial Officer) | ||||||
| b) | Initial notification/Amendment | Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Dr. Martens plc | ||||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 | ||||||
| b) | Nature of the transaction | Purchase of Ordinary shares under the Global Bonus Scheme | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information
|
| ||||||
| e) | Date of the transaction | 2024-05-30 | ||||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
